Merck & Company Inc (MRK) Stock Analysis

Merck & Company Inc (MRK) is a publicly traded company in the HEALTHCARE sector. It trades at $115.70, carries a market capitalization of $284.45B, a price-to-earnings ratio of 32.44, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for MRK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

Market Sentiment

Merck & Company Inc currently has a Bullish sentiment score of 0.19.

About Merck & Company Inc

Merck & Company Inc. is a prominent American multinational pharmaceutical corporation headquartered in Kenilworth, New Jersey, celebrated for its dedication to enhancing global health through cutting-edge pharmaceuticals and vaccines. Established in 1891 as the U.S. subsidiary of the German Merck Group, Merck has a rich history of scientific innovation, focusing on critical therapeutic areas such as oncology, infectious diseases, and cardiovascular health. The company boasts a robust pipeline...

GNG Research Analysis

GNG Research scores Merck & Company Inc (MRK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MRK.

Frequently Asked Questions

What is MRK's current dividend yield?

Merck & Company Inc (MRK) has a current dividend yield of 0.03%.

Does MRK pay dividends?

Yes, Merck & Company Inc pays dividends with a current yield of 0.03%.

What is MRK's P/E ratio?

Merck & Company Inc has a price-to-earnings (P/E) ratio of 32.44.

What is MRK's market cap?

Merck & Company Inc (MRK) has a market capitalization of $284.45B with a current stock price of $115.70.